Sampurna Chatterjee

Takeda Pharmaceuticals - Translational Scientist @ Takeda / Board of Directors @NPA

Chatterjee is passionate about serving and transforming society by making science open, inclusive, and accessible to create a welcoming, diverse environment where all can thrive. She was the co-vice chair of the Massachusetts General Hospital postdoctoral association (MGPA) in Boston where she advocated providing a platform for research and career development and communication for postdoctoral fellows. Parallelly, she served on the Diversity, Equity, and Inclusion Subcommittee (DEI) of MGPA promoting the equitable treatment of all members of the postdoctoral community, particularly those underrepresented in science and medicine.
Chatterjee is a translational scientist at Takeda Pharmaceuticals, where she focuses on bringing innovative cures to the clinic for patients with advanced and difficult-to-treat cancers. Prior to this, she developed novel therapeutics for deadly brain cancers like adult glioblastoma and pediatric medulloblastoma at the Harvard Medical School and Massachusetts General Hospital (MGH).

Corporate Partners